Ad
related to: SandozDiscover SKYTROFA® an FDA approved treatment option. HCPs: Register to receive updates. Register to learn more about this treatment option. See safety & efficacy results.
- FDA Approved SKYTROFA®
HCPs: Information about SKYTROFA®
a FDA approved treatment.
- SKYTROFA® Dosing
See the recommended dose
and administration information.
- Prescribing Information
Get prescribing info, including
dosing and administration.
- Register for More
Register to receive updates
and info on special events.
- HCP Resources
HCPs: Download helpful resources
for you and your patients.
- Safety Profile
Learn more about SKYTROFA®
established safety profile.
- FDA Approved SKYTROFA®
Search results
Sandoz is a global leader in generic pharmaceuticals and biosimilars, with a mission to discover new ways to improve and extend people's lives. Learn more about our products, our quality standards, our innovation and sustainability efforts, and our partnerships and collaborations.
- Careers
Careers - Sandoz
- About Sandoz
About Sandoz - Sandoz
- People & Culture
People & Culture - Sandoz
- Information for Customers
Sandoz US is the American branch of Sandoz, a world-renowned...
- Sandoz Customer Connect
Login to Sandoz Customer Connect™. Email Address: Password:...
- Amoxi-Clav Tablet
PrAmoxicillin Sodium and Potassium Clavulanate for Injection...
- Careers
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz.
Oct 4, 2023 · Novartis announces the planned separation of Sandoz, its Generics and Biosimilars business, into an independent company by way of a 100% spin-off. Find out the latest news, timeline, and details of the spin-off process and the new Sandoz Group AG.
Oct 4, 2023 · Novartis has separated its Generics and Biosimilars business into an independent company, Sandoz, through a dividend-in-kind distribution to shareholders. Novartis reiterates its guidance for FY2023, with sales expected to grow high single digits and core operating income low double digits to mid-teens.
Mar 5, 2024 · Sandoz, a global leader in generic and biosimilar medicines, has received FDA approval for Wyost ® and Jubbonti ®, the first and only biosimilars to denosumab, a medicine for bone loss and cancer-related skeletal events. The biosimilars are interchangeable with the reference medicines Xgeva ® and Prolia ® for all indications.
Sandoz is a public company based in Basel, Switzerland, that produces and sells generic and biosimilar medicines worldwide. Follow Sandoz on LinkedIn to learn about its purpose, products, locations, employees, updates, and events.
People also ask
Who is Sandoz Group AG?
What does Sandoz do?
What is Sandoz & Novartis?
Where is Sandoz based?
Ad
related to: SandozDiscover SKYTROFA® an FDA approved treatment option. HCPs: Register to receive updates. Register to learn more about this treatment option. See safety & efficacy results.
